eXciteOSA for Treatment of Mild Obstructive Sleep Apnea

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with mild OSA. The study is a multi-center, prospective, open-label, randomized, parallel-arm trial of eXciteOSA versus no-therapy for six weeks. Up to 200 participants will be enrolled, in order to randomized n=102.
Epistemonikos ID: b2925ff103e6d6cbb93440a6a36954e13a26b89f
First added on: May 09, 2024